UK markets closed
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • FTSE 250

    20,910.37
    -287.75 (-1.36%)
     
  • AIM

    1,183.25
    -8.61 (-0.72%)
     
  • GBP/EUR

    1.1537
    +0.0039 (+0.34%)
     
  • GBP/USD

    1.3921
    -0.0091 (-0.65%)
     
  • BTC-GBP

    33,590.50
    +958.83 (+2.94%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • DOW

    30,932.37
    -469.64 (-1.50%)
     
  • CRUDE OIL

    61.66
    -1.87 (-2.94%)
     
  • GOLD FUTURES

    1,733.00
    -42.40 (-2.39%)
     
  • NIKKEI 225

    28,966.01
    -1,202.26 (-3.99%)
     
  • HANG SENG

    28,980.21
    -1,093.96 (-3.64%)
     
  • DAX

    13,786.29
    -93.04 (-0.67%)
     
  • CAC 40

    5,703.22
    -80.67 (-1.39%)
     

London stocks climb as AstraZeneca, Indivior jumps

Shashank Nayar and Amal S
·2-min read
The London Stock Exchange Group offices are seen in the City of London, Britain

By Shashank Nayar and Amal S

(Reuters) - British stocks ended higher on Tuesday after drugmaker AstraZeneca denied reports that its COVID-19 vaccine was less effective in the elderly population, while Indivior surged after its former parent withdrew a $1.4 billion legal claim.

The blue-chip FTSE 100 index climbed 0.2%, with automakers and healthcare stocks leading the gains, while the mid-cap index rose 0.5%.

However, weakness in general retailers limited gains after British retail sales suffered their biggest annual drop since May this month, suggesting the latest lockdown is taking a heavy toll on many shops.

The mood was also dampened by a jump in Britain's unemployment rate to 5.0%, its highest in nearly five years, in the three months to November.

"Even though the unemployment rate is at 5%, it was meant to go to 5.1%. So, there were positive angles to pick among the negative news and I think that seems to have benefited sentiment alongside the pound falling," said Connor Campbell, a financial analyst at SpreadEx.

Drugmaker AstraZeneca gained 0.7% and gave the second biggest boost to the blue-chip index after it denied reports its COVID-19 vaccine was not very effective for people over 65.

The FTSE 100 has recorded consistent monthly gains since November on expectations of a vaccine-led recovery, but it has lost steam as extended lockdowns hit business activity.

The International Monetary Fund cut Britain's growth outlook for 2021 because of a resurgence in novel coronavirus cases, and forecast it would take until next year for the economy to regain its pre-pandemic strength.

Britain's Rolls-Royce dropped 1.8% after it downgraded expectations for how much its engines would fly this year.

Indivior leapt 13.1% to the top of the FTSE 250 index after it said late on Monday that former parent Reckitt Benckiser would withdraw a $1.4 billion claim against the company.

(Reporting by Shashank Nayar in Bengaluru; editing by Uttaresh.V and Subhranshu Sahu and Barbara Lewis)